DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Vernalis Research
Vernalis Research
Specialists in Small Molecule Drug Development
Drug Discovery Chemistry
2019 Analyst Day
Form 8-K Ligand Pharmaceuticals
Milner Symposium 2020
4586728.98 in 2005
An Insight Into Our Life Sciences and Healthcare Sector
Curriculum Vitae – Jac Wijkmans
When Fragments Link : a Bibliometric Perspective on the Development of Fragment-Based Drug Discovery
Vernalis Plc Annual Report and Accounts 2006 Contents
Specialists in Cancer Drug Discovery & Development
Conference Handbook 2013
Form 8-K Ligand Pharmaceuticals Incorporated
Client List LATEST
Ligand Announces an Expansion of Vernalis Collaboration with Servier for Research on Novel Oncology Targets
The Newsletter for the Society for Medicines Research
8252644.45 in 2004
Current Medicinal Chemistry, 2020, 27, 6495-6522
Top View
When Fragments Link: a Bibliometric Perspective on the Development of Fragment-Based Drug Discovery
Priorclave Customer List UK and Worldwide
Drug Discovery Chemistry Day One | Monday 18Th March 2019
FY 2006 Expenditures
Global Therapeutic Alliance Overview
Register by June 12 and Save up to $600
Annual Report
Updated-Final List of Pharma Product Patents During 2005-06 to 2009-10
Pat 0.Vp:Corelventura
Vernalis Plc Vernalis ANNUAL REPORT and ACCOUNTS 2015/16
Office of Sponsored Research Annual Report FY05
2 FG9A Nationale Patente Brevets Nationaux Brevetti Nazionali
Benefits to Attending
Drug Discovery Chemistry Are Permitted to “Track-Hop” Between Concurrent Programs
An Insight Into Our Life Sciences and Healthcare Sector 2021
Roderick E Hubbard Vernalis (R&D) Ltd, Cambridge YSBL & HYMS, Univ of York, UK Fragments 2013
Fragment-Based Drug Discovery Approaches
Patents Office Journal